Fiera Capital Corp Acquires New Holdings in ASP Isotopes Inc. (NASDAQ:ASPI)

Fiera Capital Corp purchased a new stake in shares of ASP Isotopes Inc. (NASDAQ:ASPI - Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 260,000 shares of the company's stock, valued at approximately $723,000. Fiera Capital Corp owned approximately 0.38% of ASP Isotopes as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in ASPI. Vanguard Group Inc. boosted its position in ASP Isotopes by 479.1% during the 1st quarter. Vanguard Group Inc. now owns 1,021,019 shares of the company's stock valued at $4,217,000 after acquiring an additional 844,705 shares in the last quarter. Marshall Wace LLP raised its stake in ASP Isotopes by 389.6% during the 2nd quarter. Marshall Wace LLP now owns 545,072 shares of the company's stock valued at $1,668,000 after buying an additional 433,734 shares during the last quarter. Bank of New York Mellon Corp purchased a new stake in ASP Isotopes during the 2nd quarter valued at $381,000. HTLF Bank raised its stake in ASP Isotopes by 197.0% during the 2nd quarter. HTLF Bank now owns 105,538 shares of the company's stock valued at $323,000 after buying an additional 70,000 shares during the last quarter. Finally, Virtu Financial LLC grew its position in shares of ASP Isotopes by 477.0% during the 1st quarter. Virtu Financial LLC now owns 83,677 shares of the company's stock valued at $346,000 after acquiring an additional 69,176 shares during the period. Hedge funds and other institutional investors own 16.80% of the company's stock.

Analyst Ratings Changes

A number of brokerages have recently issued reports on ASPI. HC Wainwright cut their price objective on shares of ASP Isotopes from $5.50 to $4.50 and set a "buy" rating for the company in a research report on Wednesday, August 7th. Canaccord Genuity Group restated a "buy" rating and set a $4.50 price objective on shares of ASP Isotopes in a research report on Friday, October 18th. Finally, Canaccord Genuity Group started coverage on ASP Isotopes in a research report on Friday, October 4th. They set a "buy" rating and a $4.50 price objective for the company.

ASP Isotopes Trading Down 3.2 %

NASDAQ ASPI traded down $0.28 during trading on Monday, hitting $8.49. The stock had a trading volume of 2,949,319 shares, compared to its average volume of 1,427,333. The company has a debt-to-equity ratio of 2.06, a quick ratio of 4.00 and a current ratio of 4.00. The stock has a market capitalization of $604.15 million, a price-to-earnings ratio of -13.92 and a beta of 3.88. ASP Isotopes Inc. has a one year low of $1.45 and a one year high of $9.33. The stock has a 50 day simple moving average of $3.89 and a 200 day simple moving average of $3.55.

ASP Isotopes (NASDAQ:ASPI - Get Free Report) last posted its quarterly earnings results on Monday, August 19th. The company reported ($0.24) earnings per share for the quarter. The firm had revenue of $1.02 million for the quarter. Sell-side analysts predict that ASP Isotopes Inc. will post -0.24 earnings per share for the current year.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.